Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -91,779 | -69,241 | -48,548 | -83,965 | -7,969 |
| Depreciation Amortization | 4,640 | 3,267 | 1,772 | 667 | 587 |
| Accounts receivable | 14 | 106 | -142 | 448 | -745 |
| Accounts payable and accrued liabilities | -512 | 931 | 897 | 659 | -1 |
| Other Working Capital | -1,087 | 3,305 | 2,660 | 797 | -529 |
| Other Operating Activity | 15,740 | 11,191 | 7,635 | 24,086 | 1,045 |
| Operating Cash Flow | $-72,984 | $-50,441 | $-35,726 | $-57,308 | $-7,612 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,095 | -7,220 | -5,421 | -804 | -366 |
| Purchase Of Investment | -54,895 | -33,276 | -101,649 | N/A | N/A |
| Sale Of Investment | 63,737 | 42,548 | 20,617 | N/A | N/A |
| Investing Cash Flow | $-3,253 | $2,052 | $-86,453 | $-804 | $-366 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 3,500 |
| Debt Issued | 45,000 | 20,000 | N/A | 386 | 550 |
| Debt Repayment | -32,711 | -15 | -4 | -1,187 | -200 |
| Common Stock Issued | 66,639 | 1,142 | 829 | 160,859 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -5,056 | N/A |
| Dividend Paid | N/A | N/A | N/A | -155 | N/A |
| Other Financing Activity | -442 | -199 | -7 | 83,699 | 13,664 |
| Financing Cash Flow | $78,486 | $20,928 | $818 | $238,546 | $17,514 |
| Beginning Cash Position | 42,780 | 70,241 | 191,602 | 11,168 | 1,632 |
| End Cash Position | 45,029 | 42,780 | 70,241 | 191,602 | 11,168 |
| Net Cash Flow | $2,249 | $-27,461 | $-121,361 | $180,434 | $9,536 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,984 | -50,441 | -35,726 | -57,308 | -7,612 |
| Capital Expenditure | -12,134 | -7,220 | -5,421 | -804 | -366 |
| Free Cash Flow | -85,118 | -57,661 | -41,147 | -58,112 | -7,978 |